A phase I study of cetuximab in combination with erlotinib in patients with advanced solid malignancies
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2015
At a glance
- Drugs Cetuximab; Erlotinib
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 02 Nov 2007 Status change from in progress to completed.
- 13 Nov 2005 New trial record.